LY2979165

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for LY2979165, covering 2011-06-27 to 2013-08-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2979165 and LY2140023 in Healthy Volunteers [Phase 1]